Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ketamine abuse, biliary tract disease, and secondary sclerosing cholangitis.

× No keyword cloud information.

9 in total

Review 1. Secondary Sclerosing Cholangitis: a Review of Recent Literature.

Authors: John Brooling; Rolando Leal
Journal: Curr Gastroenterol Rep Date: 2017-09

2. Bile Duct Injury due to Drug Induced Liver Injury.

Authors: Priya Grewal; Jawad Ahmad
Journal: Curr Hepatol Rep Date: 2019-07-15

3. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper.

Authors: Thomas Marjot; Christiane S Eberhardt; Tobias Boettler; Luca S Belli; Marina Berenguer; Maria Buti; Rajiv Jalan; Mario U Mondelli; Richard Moreau; Daniel Shouval; Thomas Berg; Markus Cornberg
Journal: J Hepatol Date: 2022-07-20 Impact factor: 30.083

Review 4. Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.

Authors: Pedro Martins; Mariana Verdelho Machado
Journal: GE Port J Gastroenterol Date: 2019-07-30

Review 5. Drug-induced cholestasis.

Authors: Vinay Sundaram; Einar S Björnsson
Journal: Hepatol Commun Date: 2017-09-11

Review 6. Ketamine plus Alcohol: What We Know and What We Can Expect about This.

Authors: Natalia Harumi Correa Kobayashi; Sarah Viana Farias; Diandra Araújo Luz; Kissila Márvia Machado-Ferraro; Brenda Costa da Conceição; Cinthia Cristina Menezes da Silveira; Luanna Melo Pereira Fernandes; Sabrina de Carvalho Cartágenes; Vânia Maria Moraes Ferreira; Enéas Andrade Fontes-Júnior; Cristiane do Socorro Ferraz Maia
Journal: Int J Mol Sci Date: 2022-07-15 Impact factor: 6.208

7. Long-Term Outcomes After Drug-Induced Liver Injury.

Authors: Paul H Hayashi; Einar S Bjornsson
Journal: Curr Hepatol Rep Date: 2018-07-02

8. Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient With COVID-19.

Authors: Sally A I Knooihuizen; Ariel Aday; William M Lee
Journal: Hepatology Date: 2021-05-28 Impact factor: 17.298

9. Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case Series.

Authors: Samantha Cotter; Jennie Wong; Neha Gada; Rajdeep Gill; S Christopher Jones; Grace Chai; Daniel Foster; Mark Avigan; Mallika Mundkur
Journal: Drug Saf Date: 2021-10-26 Impact factor: 5.606

9 in total